What does the GSK symbol mean?

The GSK logo is an orange tablet-shaped (or heart-shaped) emblem with the company name written in white Frutiger typerface. The combination of orange and white expresses the company’s striving to do good to its every customer and provide high quality products.

What does the GSK symbol mean?

The GSK logo is an orange tablet-shaped (or heart-shaped) emblem with the company name written in white Frutiger typerface. The combination of orange and white expresses the company’s striving to do good to its every customer and provide high quality products.

What are GSK 3 global businesses?

GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare.

Does GSK have a future?

GSK publishes Prospectus and Circular We expect to deliver a step change in performance with major new commitments to sales and profit growth including more than 5% sales CAGR 2021-26, more than 10% adjusted operating profit CAGR 2021-26 expected and an ambition to deliver more than £33 billion sales by 2031.

Is GSK working on Covid vaccine?

In addition to our work on adjuvanted vaccines, we are working with CureVac to develop mRNA vaccines potentially effective against multiple COVID-19 variants. We announced encouraging pre-clinical test results in 2021 with clinical testing to begin in 2022.

Is GSK part of Unilever?

New Delhi: Consumer goods company Unilever Plc’s – that made three separate offers for GlaxoSmithKline’s (GSK) consumer business – comes nearly two years after its Indian arm Hindustan Unilever Ltd (HUL) successfully merged with GlaxoSmithKline Consumer Healthcare Limited (GSKCH) in India, giving it access to health …

What is GSK currently working on?

Our focus areas What we’re working on We are strengthening our pipeline through a focus on science related to the immune system, the use of human genetics and advanced technologies. Our early stage research is not constrained by therapy areas with teams actively encouraged to follow the science.